The Cardiovascular Risk Factor Profiles among End-stage Renal Failure Patients Treated with Continuous Ambulatory Peritoneal Dialysis and Intermittent Hemodialysis

被引:8
|
作者
Zamiah, S. A. K. Sharifah [1 ]
Draman, Che Rosle [2 ]
Seman, Mohd. Ramli [3 ]
Safhan, A. Fariz [3 ]
Rozalina, R. [2 ]
Ruzni, N. I. Nik [4 ]
机构
[1] Int Islamic Univ Malaysia, Kulliyyah Allied Hlth Sci, Dept Biomed Sci, Pahang, Malaysia
[2] Int Islamic Univ Malaysia, Kulliyyah Med, Dept Internal Med, Pahang, Malaysia
[3] Hosp Tengku Ampuan Afzan, Dept Nephrol, Pahang, Malaysia
[4] Int Islamic Univ Malaysia, Kulliyyah Sci, Pahang, Malaysia
关键词
D O I
10.4103/1319-2442.225185
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Cardiovascular (CV) event is the most common cause of death in dialysis patients. Both traditional and nontraditional CV risk factors related to malnutrition, inflammation, and anemia are commonly found in this population. This study was conducted to evaluate the burden factors of CV risk factors and its management in our regularly dialyzed patients. It was a single-center, cross-sectional analysis of prevalent intermittent hemodialysis (IHD) and continuous ambulatory peritoneal dialysis (CAPD) patients followed up in our hospital. Both the traditional and non-traditional CV risk factors were recorded and compared between the two groups. Eighty-eight patients were recruited. Forty-five were treated with CAPD and 43 patients were treated with IHD. The mean age was 49.5 +/- 15.17 years old and 54.5% were females. Eighty percent were Malay followed by Chinese (14.7%) and Indian (5.7%). Thirty-eight percent were hypertensive and 17% were diabetic. The mean age of CAPD patients was 48.9 +/- 16.9 compared to 50 +/- 13.5 years old for IHD patients (P > 0.05). The body mass index (BMI) of CAPD patients was 23.9 kg/m(2) versus 21.7 kg/m(2) of the IHD (P = 0.04). The systolic and diastolic blood pressure of CAPD patients were 158 and 89 mm Hg in comparison to 141 and 72 mm Hg in IHD patients (P <0.001) and their total and low-density lipoprotein cholesterol level were 5.93 mmol/L and 3.84 mmol/L versus 4.79 mmol/L and 2.52 mmol/L, respectively (P <= 0.001). The CAPD patients were hyperglycemic more than IHD patients, although it was not statistically significant. All the nontraditional CV risk factors except serum albumin were comparable between the two groups. Serum albumin in CAPD patients was 35.5 g/L compared to 40.8 g/L in the IHD patients (P <0.001). In our prevalent dialysis-dependent patients, both traditional and non-traditional CV risk factors are common. Due to the prolonged and continuous glucose exposure from the peritoneal dialysis fluid, the CAPD patients had highly atherogenic serum, higher BMI, and intensified inflammation which pre-disposed them to higher CV events.
引用
收藏
页码:114 / 119
页数:6
相关论文
共 50 条
  • [21] Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis
    Nguyen, Nghia Nhu
    Duong, Phieu Van
    Mai, Tan Huynh Ngoc
    Vo, Nghia Hoang
    Luong, Dinh Kim
    Ngo, Toan Hoang
    INTERNATIONAL JOURNAL OF CLINICAL PRACTICE, 2023, 2023
  • [22] Is there different risk of cancer among end-stage renal disease patients undergoing hemodialysis and peritoneal dialysis?
    Lee, Yi-Che
    Hung, Shih-Yuan
    Wang, Hao-Kuang
    Lin, Chi-Wei
    Wang, Hsi-Hao
    Chang, Min-Yu
    Sung, Junne-Ming
    Chiou, Yuan-Yow
    Lin, Sheng-Hsiang
    CANCER MEDICINE, 2018, 7 (02): : 485 - 498
  • [23] MULTICENTER STUDY OF LIPOPROTEIN(A) AND APOLIPOPROTEIN(A) PHENOTYPES IN PATIENTS WITH END-STAGE RENAL-DISEASE TREATED BY HEMODIALYSIS OR CONTINUOUS AMBULATORY PERITONEAL-DIALYSIS
    KRONENBERG, F
    KONIG, P
    NEYER, U
    AUINGER, M
    PRIBASNIG, A
    LANG, U
    REITINGER, J
    PINTER, G
    UTERMANN, G
    DIEPLINGER, H
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (01): : 110 - 120
  • [24] Transforming Growth Factor Beta 1 as a Risk Factor for Cardiovascular Diseases in End-Stage Renal Disease Patients Treated With Peritoneal Dialysis
    Janda, Katarzyna
    Krzanowski, Marcin
    Dumnicka, Paulina
    Kusnierz-Cabala, Beata
    Krasniak, Andrzej
    Sulowicz, Wladyslaw
    CLINICAL LABORATORY, 2014, 60 (07) : 1163 - 1168
  • [25] Activation of chronic inflammation and comorbidity in end-stage renal disease patients treated with continuous ambulatory peritoneal dialysis.
    Shifris, I. M.
    Dudar, I. O.
    Driyanska, V. E.
    Shymova, A. U.
    MEDICNI PERSPEKTIVI, 2020, 25 (02): : 108 - +
  • [26] INTERMITTENT PERITONEAL-DIALYSIS IN THE MANAGEMENT OF END-STAGE RENAL-FAILURE
    WALKER, RG
    ATKINS, RC
    THOMSON, NM
    SCOTT, DF
    AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1980, 10 (01): : 119 - 119
  • [27] INTERMITTENT PERITONEAL-DIALYSIS IN THE TREATMENT OF END-STAGE RENAL-FAILURE
    WALKER, RG
    ATKINS, RC
    THOMSON, NM
    SCOTT, DF
    MEDICAL JOURNAL OF AUSTRALIA, 1979, 2 (08) : 393 - 397
  • [28] Comparison of arterial stiffness in end-stage renal disease patients treated with peritoneal dialysis or hemodialysis
    Strozecki, Pawel
    Donderski, Rafal
    Kardymowicz, Anna
    Manitius, Jacek
    POLSKIE ARCHIWUM MEDYCYNY WEWNETRZNEJ-POLISH ARCHIVES OF INTERNAL MEDICINE, 2012, 122 (1-2): : 33 - 38
  • [29] ECONOMIC EVALUATION OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS (CAPD) AND HEMODIALYSIS (HD) FOR END-STAGE RENAL DISEASE (ESRD) PATIENTS IN INDONESIA
    Nugraha, R. R.
    Thabrany, H.
    Putri, S.
    Pujiyanti, E.
    VALUE IN HEALTH, 2017, 20 (05) : A249 - A249
  • [30] Inflammation and oxidative stress in end-stage renal disease patients treated with hemodialysis or peritoneal dialysis
    Filiopoulos, Vassilis
    Hadjiyannakos, Dimitrios
    Takouli, Lambrini
    Metaxaki, Polixeni
    Sideris, Vasilis
    Vlassopoulos, Dimosthenis
    INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS, 2009, 32 (12): : 872 - 882